(Total Views: 372)
Posted On: 04/22/2021 10:48:45 PM
Post# of 653
$RLFTF DD by Equalizer on Yh-0: Pg. 211 SEC Document (Commercialization)
Relief retains the right to identify commercialization partners for countries outside the parties’ territories (called ROW (rest of world) in joint agreement, which includes Brazil, Mexico, India, etc.)
"This is one reason why Relief is anxious to get the RCT trial results and EUA submitted so they can move forward with plans in Europe and ROW !"
---
Right now the Rest of World (outside US, Canada & Israel), is at all time peak highs for daily, weekly and monthly cases.
60 day endpoint was ~2/24.
Imagine if EUA was filed within 30 days (3/24) of 60 day endpoint and approved within 30 days of application (4/24).
Those were not unreasonable goals.
And in that case would be available to Rest of World for review.
Let’s hope Dr J has submitted or will be soon and that at this point FDA can approve within hours to make up for past errors.
see yh-0 thread...
Relief retains the right to identify commercialization partners for countries outside the parties’ territories (called ROW (rest of world) in joint agreement, which includes Brazil, Mexico, India, etc.)
"This is one reason why Relief is anxious to get the RCT trial results and EUA submitted so they can move forward with plans in Europe and ROW !"
---
Right now the Rest of World (outside US, Canada & Israel), is at all time peak highs for daily, weekly and monthly cases.
60 day endpoint was ~2/24.
Imagine if EUA was filed within 30 days (3/24) of 60 day endpoint and approved within 30 days of application (4/24).
Those were not unreasonable goals.
And in that case would be available to Rest of World for review.
Let’s hope Dr J has submitted or will be soon and that at this point FDA can approve within hours to make up for past errors.
see yh-0 thread...
(0)
(0)
$MJ
